Gender‐Specific Effects on Verapamil Pharmacokinetics and Pharmacodynamics in Humans
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Pharmacokinetic studies of i.v. and oral racemic verapamil and 14 C‐erythromycin breath tests (ERBT) were performed in 84 healthy men (n = 42) and women (n = 42). Verapamil was measured by HPLC, concentration versus time data were analyzed by noncompartmental models, protein binding was measured by equilibrium dialysis, and statistical analyses were performed by ANOVA. Clearance of i.v. and p.o. verapamil was 13.7 ± 4.3 and 58.4 ± 35 ml/min/kg (mean ± SD) in women compared to 12.6 ± 3.4 and 82.6 ± 70 ml/min/kg in men (p = 0.076). Bioavailability was higher in women (0.25 ± 0.09) compared to men (0.20 ± 0.09, p = 0.019) with a significant Gender × Formulation interaction (p = 0.04). ERBT were higher in women (p < 0.0001). Verapamil (i.v. and p.o.) decreased blood pressure in all subjects with greater heart rate increases after p.o. verapamil in women compared to men (p = 0.041). The findings suggest that sex‐specific differences in drug metabolism may occur in both the gut and the liver and involve multiple metabolic pathways and that pharmacokinetic differences will alter pharmacodynamic responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacokinetic drug interactions with oral contraceptives
Back, D. J., & Orme, M. L. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199018060-00004 · Cited by 209
Cited by
Sex Differences in Pharmacokinetics and Pharmacodynamics
Soldin, O. P., & Mattison, D. R. (2009) · Clinical Pharmacokinetics · doi:10.2165/00003088-200948030-00001 · Cited by 1,163
Sex Differences in Pharmacokinetics and Pharmacodynamics
Gandhi, M., Aweeka, F., Greenblatt, R. M., & Blaschke, T. F. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121453 · Cited by 542
The Influence of Sex on Pharmacokinetics
Schwartz, J. B. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342020-00001 · Cited by 467
Self-citationGender differences in drug responses
FRANCONI, F., BRUNELLESCHI, S., STEARDO, L., & CUOMO, V (2007) · Pharmacological Research · doi:10.1016/j.phrs.2006.11.001 · Cited by 454
How Important Are Gender Differences in Pharmacokinetics?
Meibohm, B., Beierle, I., & Derendorf, H. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241050-00002 · Cited by 454
Metadata
- Authors
- Krecic‐Shepard, M. E., Barnas, C. R., Slimko, J., Jones, M. P., & Schwartz, J. B.
- Venue
- The Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2000-03
- Volume
- 40
- Issue
- 3
- Pages
- 219-230
- ISSN
- 0021-9754 (ISSN-L)
- 0091-2700
- 1552-4604
- OpenAlex
- W2127599727
- Cited by
- 116
- References
- 1
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gender‐Specific Effects on Verapamil Pharmacokinetics and Pharmacodynamics in Humans. https://app.cochat.ai/papers/10.1177/00912700022008883
- The paper
- Krecic‐Shepard, M. E., Barnas, C. R., Slimko, J., Jones, M. P., & Schwartz, J. B. (2000). Gender‐Specific Effects on Verapamil Pharmacokinetics and Pharmacodynamics in Humans. The Journal of Clinical Pharmacology. https://doi.org/10.1177/00912700022008883
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.